DEA Judge Backs Federal Ban On 2 Research Chemicals – Law360
Law360 reports that A U.S. Drug Enforcement Administration judge has determined that two unrestrictive research chemicals DOI & DOC belong in Schedule I, the most strigent tier of prohibited substances under the Federal Controlled Substances Act. Read more here.
This recommendation directly undermines the future of psychedelic science and sets a dangerous precedent for research freedom.
The groundbreaking multi-year long effort by SSDP’s Science Policy Committee to keep crucial medical research legal marked the first time “research harm”—the harm caused to future and ongoing research by onerous regulatory decisions that disincentivize scientific research in a given field—has been formally considered in a DEA scheduling case, setting a powerful precedent for how such decisions impact scientific progress.
“For over a century, United States drug policy has silenced scientific voices and bypassed the facts to create harmful laws rooted in misinformation and fear,” said Murti. “Adding DOI and DOC to Schedule I of the Controlled Substances Act would undermine decades of progress in neuroscience and pharmacology and SSDP and the young scientists leading this fight are committed to protecting the future of scientific and medical research.”
